Literature DB >> 22895526

Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis.

Masakazu Fukunaga1, Yasuko Yamamoto, Misaki Kawasoe, Yuko Arioka, Yuki Murakami, Masato Hoshi, Kuniaki Saito.   

Abstract

Indoleamine 2,3-dioxygenase 1 (IDO1) catabolizes tryptophan to kynurenine at the first step of tryptophan metabolism. Recently, in addition to IDO1, a new isoform called IDO2 was identified. In this study, we examined the tissue expression pattern of IDO2 mRNA and the cellular localization of expressed IDO2 protein in mice. IDO1 mRNA expression was observed in the colon and epididymis, whereas IDO2 mRNA expression was found in the cerebral cortex, liver, kidney, and epididymis. Immunohistochemical analysis revealed that IDO2 protein was exclusively expressed on the hepatocytes, interlobular bile ducts, neuronal cells of the cerebrum cortex, Purkinje cells of the cerebellum cortex, lamina epithelialis, proximal convoluted tubule, and the collecting tubule of the kidney. In the epididymis, IDO1 protein expression was restricted to the caput, whereas IDO2 protein expression was observed on the caput, corpus, and cauda. Both IDO proteins were expressed on the caput, but both showed a different protein expression pattern in the segments. Immunohistochemical analysis in IDO1(-/-) mouse epididymis showed that IDO2 protein was extensively upregulated due to the loss of IDO1 expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895526      PMCID: PMC3524572          DOI: 10.1369/0022155412458926

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  18 in total

1.  Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state.

Authors:  Aicha Jrad-Lamine; Joelle Henry-Berger; Pascal Gourbeyre; Christelle Damon-Soubeyrand; Alain Lenoir; Lydie Combaret; Fabrice Saez; Ayhan Kocer; Shigenobu Tone; Dietmar Fuchs; Wentao Zhu; Peter J Oefner; David H Munn; Andrew L Mellor; Najoua Gharbi; Rémi Cadet; R John Aitken; Joël R Drevet
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

2.  Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity.

Authors:  Nitin K Gupta; Ameet I Thaker; Navya Kanuri; Terrence E Riehl; Christopher W Rowley; William F Stenson; Matthew A Ciorba
Journal:  Inflamm Bowel Dis       Date:  2011-08-05       Impact factor: 5.325

3.  Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.

Authors:  Christopher Jonathan Daraius Austin; B M Mailu; G J Maghzal; A Sanchez-Perez; S Rahlfs; K Zocher; H J Yuasa; J W Arthur; K Becker; R Stocker; N H Hunt; H J Ball
Journal:  Amino Acids       Date:  2010-02-07       Impact factor: 3.520

4.  Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice.

Authors:  R Yoshida; T Nukiwa; Y Watanabe; M Fujiwara; F Hirata; O Hayaishi
Journal:  Arch Biochem Biophys       Date:  1980-08       Impact factor: 4.013

5.  The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse.

Authors:  Masato Hoshi; Kuniaki Saito; Akira Hara; Ayako Taguchi; Hirofumi Ohtaki; Ryo Tanaka; Hidetsugu Fujigaki; Yosuke Osawa; Masao Takemura; Hidetoshi Matsunami; Hiroyasu Ito; Mitsuru Seishima
Journal:  J Immunol       Date:  2010-08-06       Impact factor: 5.422

Review 6.  Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.

Authors:  Helen J Ball; Hajime J Yuasa; Christopher J D Austin; Silvia Weiser; Nicholas H Hunt
Journal:  Int J Biochem Cell Biol       Date:  2008-01-11       Impact factor: 5.085

7.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Authors:  Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

8.  CTLA-4-Ig regulates tryptophan catabolism in vivo.

Authors:  Ursula Grohmann; Ciriana Orabona; Francesca Fallarino; Carmine Vacca; Filippo Calcinaro; Alberto Falorni; Paola Candeloro; Maria L Belladonna; Roberta Bianchi; Maria C Fioretti; Paolo Puccetti
Journal:  Nat Immunol       Date:  2002-09-30       Impact factor: 25.606

9.  IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.

Authors:  Stefan Löb; Alfred Königsrainer; Derek Zieker; Björn L D M Brücher; Hans-Georg Rammensee; Gerhard Opelz; Peter Terness
Journal:  Cancer Immunol Immunother       Date:  2008-04-17       Impact factor: 6.968

10.  Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

Authors:  Guido Frumento; Rita Rotondo; Michela Tonetti; Gianluca Damonte; Umberto Benatti; Giovanni Battista Ferrara
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more
  31 in total

1.  IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.

Authors:  Richard Metz; Courtney Smith; James B DuHadaway; Phillip Chandler; Babak Baban; Lauren M F Merlo; Elizabeth Pigott; Martin P Keough; Sonja Rust; Andrew L Mellor; Laura Mandik-Nayak; Alexander J Muller; George C Prendergast
Journal:  Int Immunol       Date:  2014-01-08       Impact factor: 4.823

2.  Differential expression and regulation of Ido2 in the mouse uterus during peri-implantation period.

Authors:  Dang-Dang Li; Xin-Yuan Liu; Chuan-Hui Guo; Liang Yue; Zhan-Qing Yang; Hang Cao; Bin Guo; Zhan-Peng Yue
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-11-19       Impact factor: 2.416

3.  Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases.

Authors:  Alexandra K Brooks; Tiffany M Janda; Marcus A Lawson; Jennifer L Rytych; Robin A Smith; Cecilia Ocampo-Solis; Robert H McCusker
Journal:  Brain Behav Immun       Date:  2017-02-16       Impact factor: 7.217

4.  IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis.

Authors:  Lauren M F Merlo; Elizabeth Pigott; James B DuHadaway; Samantha Grabler; Richard Metz; George C Prendergast; Laura Mandik-Nayak
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

5.  Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD.

Authors:  Ludovic Belle; Vivian Zhou; Kara L Stuhr; Margaret Beatka; Emily M Siebers; Jennifer M Knight; Michael W Lawlor; Casey Weaver; Misato Hashizume; Cecilia J Hillard; William R Drobyski
Journal:  JCI Insight       Date:  2017-07-20

Review 6.  Indoleamine 2,3 dioxygenase in intestinal disease.

Authors:  Matthew A Ciorba
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

7.  Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues.

Authors:  Yoshiji Ohta; Hisako Kubo; Koji Yashiro; Koji Ohashi; Yuji Tsuzuki; Naoya Wada; Yasuko Yamamoto; Kuniaki Saito
Journal:  J Physiol Sci       Date:  2016-06-30       Impact factor: 2.781

8.  Glia- and tissue-specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone.

Authors:  Carlos R Dostal; Nicolaus S Gamsby; Marcus A Lawson; Robert H McCusker
Journal:  Brain Behav Immun       Date:  2017-12-11       Impact factor: 7.217

Review 9.  Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.

Authors:  Nady Braidy; Jade Berg; James Clement; Fatemeh Khorshidi; Anne Poljak; Tharusha Jayasena; Ross Grant; Perminder Sachdev
Journal:  Antioxid Redox Signal       Date:  2018-05-11       Impact factor: 8.401

Review 10.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.

Authors:  Ping Song; Tharmarajan Ramprasath; Huan Wang; Ming-Hui Zou
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.